ScholarIQanswers from OpenAlex

515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan

PaperCitations, authors & open-access status

515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan have?

ScholarIQcitation count

515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan has 0 citations in the OpenAlex counts ScholarIQ stores.

When was 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan published?

ScholarIQyear

515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan has 2025 year in the ScholarIQ index.

What is the open-access status of 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan?

ScholarIQoa status

515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan has closed oa status in the ScholarIQ index.

What is the DOI of 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan?

ScholarIQdoi

The DOI for 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan is on the source record.

What is the OpenAlex record for 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan?

ScholarIQopenalex

The OpenAlex for 515P Metastatic castration sensitive prostate cancer patient treatment preferences in China, South Korea and Japan is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial